skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 34  for All Library Resources

Results 1 2 next page
Refined by: resource type: Standards remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes
Material Type:
Standards
Add to My Research

Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

2
Ponesimod for treating relapsing–remitting multiple sclerosis
Material Type:
Standards
Add to My Research

Ponesimod for treating relapsing–remitting multiple sclerosis

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

3
Givosiran for treating acute hepatic porphyria
Material Type:
Standards
Add to My Research

Givosiran for treating acute hepatic porphyria

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

4
Romosozumab for treating severe osteoporosis
Material Type:
Standards
Add to My Research

Romosozumab for treating severe osteoporosis

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

5
Ovarian cancer: identifying and managing familial and genetic risk
Material Type:
Standards
Add to My Research

Ovarian cancer: identifying and managing familial and genetic risk

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

6
Fetal alcohol spectrum disorder
Material Type:
Standards
Add to My Research

Fetal alcohol spectrum disorder

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

7
Caesarean birth
Material Type:
Standards
Add to My Research

Caesarean birth

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

8
Abortion care
Material Type:
Standards
Add to My Research

Abortion care

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

9
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer
Material Type:
Standards
Add to My Research

Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

10
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
Material Type:
Standards
Add to My Research

Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

11
Abortion care
Material Type:
Standards
Add to My Research

Abortion care

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

12
Antenatal care
Material Type:
Standards
Add to My Research

Antenatal care

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

13
Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
Material Type:
Standards
Add to My Research

Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

14
Intrapartum care: existing medical conditions and obstetric complications
Material Type:
Standards
Add to My Research

Intrapartum care: existing medical conditions and obstetric complications

NICE Guidance, 2020

Copyrights: © NICE 2020 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

15
Heart valve disease presenting in adults: investigation and management
Material Type:
Standards
Add to My Research

Heart valve disease presenting in adults: investigation and management

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

16
Postnatal care
Material Type:
Standards
Add to My Research

Postnatal care

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

17
Pelvic floor dysfunction: prevention and non-surgical management
Material Type:
Standards
Add to My Research

Pelvic floor dysfunction: prevention and non-surgical management

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

18
Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab
Material Type:
Standards
Add to My Research

Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

19
Intrapartum care for women with existing medical conditions or obstetric complications and their babies
Material Type:
Standards
Add to My Research

Intrapartum care for women with existing medical conditions or obstetric complications and their babies

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

20
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
Material Type:
Standards
Add to My Research

Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

Results 1 - 20 of 34  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2017  (4)
  2. 2017 To 2018  (9)
  3. 2019 To 2020  (7)
  4. 2021 To 2023  (14)
  5. After 2023  (1)
  6. More options open sub menu

Searching Remote Databases, Please Wait